Magnetic nanoparticles for ferroptosis cancer therapy with diagnostic imaging.
Magnetic nanoparticles for ferroptosis cancer therapy with diagnostic imaging.
复制标题
DOI:
10.1016/j.bioactmat.2023.09.015
复制
发表时间:
2024-02
影响因子:
18.9
通讯作者:
中科院分区:
文献类型:
--
作者:
Ferroptosis offers a novel method for overcoming therapeutic resistance of cancers to conventional cancer treatment regimens. Its effective use as a cancer therapy requires a precisely targeted approach, which can be facilitated by using nanoparticles and nanomedicine, and their use to enhance ferroptosis is indeed a growing area of research. While a few review papers have been published on iron-dependent mechanism and inducers of ferroptosis cancer therapy that partly covers ferroptosis nanoparticles, there is a need for a comprehensive review focusing on the design of magnetic nanoparticles that can typically supply iron ions to promote ferroptosis and simultaneously enable targeted ferroptosis cancer nanomedicine. Furthermore, magnetic nanoparticles can locally induce ferroptosis and combinational ferroptosis with diagnostic magnetic resonance imaging (MRI). The use of remotely controllable magnetic nanocarriers can offer highly effective localized image-guided ferroptosis cancer nanomedicine. Here, recent developments in magnetically manipulable nanocarriers for ferroptosis cancer nanomedicine with medical imaging are summarized. This review also highlights the advantages of current state-of-the-art image-guided ferroptosis cancer nanomedicine. Finally, image guided combinational ferroptosis cancer therapy with conventional apoptosis-based therapy that enables synergistic tumor therapy is discussed for clinical translations. Recent advances in the use of magnetic nanoparticles for ferroptosis cancer nanomedicine are summarized. The advantages of image-guided ferroptosis cancer nanomedicine are overviewed. The rational design and fabrication of magnetic nanoparticles to enhance local ferroptosis induction are described. Challenges and opportunities for image-guided ferroptosis cancer nanomedicine in clinical applications are provided.
登录
查看更多内容
影响因子:
19
作者:
Bae, Gunhyu;Jeon, Yoo Sang;Kang, Heemin
通讯作者:
Kang, Heemin
影响因子:
14.8
作者:
Doll S;Proneth B;Tyurina YY;Panzilius E;Kobayashi S;Ingold I;Irmler M;Beckers J;Aichler M;Walch A;Prokisch H;Trümbach D;Mao G;Qu F;Bayir H;Füllekrug J;Scheel CH;Wurst W;Schick JA;Kagan VE;Angeli JP;Conrad M
通讯作者:
Conrad M
影响因子:
7.4
作者:
Circu, Magdalena L.;Aw, Tak Yee
通讯作者:
Aw, Tak Yee
影响因子:
3
作者:
Daniels, Tracy R.;Bernabeu, Ezequiel;Rodriguez, Jose A.;Patel, Shabnum;Kozman, Maggie;Chiappetta, Diego A.;Holler, Eggehard;Ljubimova, Julia Y.;Helguera, Gustavo;Penichet, Manuel L.
通讯作者:
Penichet, Manuel L.
影响因子:
12.4
作者:
Balihodzic, Amar;Prinz, Felix;Dengler, Michael A.;Calin, George A.;Jost, Philipp J.;Pichler, Martin
通讯作者:
Pichler, Martin